Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Vidya G. Bettada"'
Autor:
Venugopal R. Bovilla, Mahadevaswamy G. Kuruburu, Vidya G. Bettada, Jayashree Krishnamurthy, Olga A. Sukocheva, Rajesh K. Thimmulappa, Nanjunda Swamy Shivananju, Janardhan P. Balakrishna, SubbaRao V. Madhunapantula
Publikováno v:
Biomedicines, Vol 9, Iss 9, p 1119 (2021)
Nuclear factor erythroid-2 related factor-2 (Nrf2) is an oxidative stress-response transcriptional activator that promotes carcinogenesis through metabolic reprogramming, tumor promoting inflammation, and therapeutic resistance. However, the extensio
Externí odkaz:
https://doaj.org/article/43fb3e14c04a4cddb18f2b5854432abf
Autor:
Venugopal R Bovilla, Preethi G Anantharaju, Sireesh Dornadula, Prashanthkumar M Veeresh, Mahadevaswamy G Kuruburu, Vidya G Bettada, Kunka Mohanram Ramkumar, SubbaRao V Madhunapantula
Publikováno v:
Asian Pacific Journal of Tropical Biomedicine, Vol 11, Iss 6, Pp 244-253 (2021)
Objective: To assess the nuclear factor-erythroid 2-related factor-2 (Nrf2) modulatory effect of caffeic acid and protocatechuic acid and determine the anti-tumor activity of these phenolic compounds against Ehrlich ascites carcinoma growth in mice.
Externí odkaz:
https://doaj.org/article/fcb8100818e54516997582b415752df6
Autor:
Jaskiran Kaur, Monica Gulati, Paras Famta, Leander Corrie, Ankit Awasthi, Sumant Saini, Gopal L. Khatik, Vidya G. Bettada, SubbaRao V. Madhunapantula, Keshav Raj Paudel, Gaurav Gupta, Dinesh Kumar Chellappan, Mohammed F. Arshad, Jon Adams, Kuppusamy Gowthamarajan, Kamal Dua, Philip M. Hansbro, Sachin Kumar Singh
Publikováno v:
International Journal of Pharmaceutics. 624:121987
The co-formulation of glyburide (Gly) and vanillic acid (VA) as such in the form of nanomedicine has never been explored to treat metabolic diseases including type 2 diabetes mellitus. Both the drugs possess dissolution rate-limited oral bioavailabil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d88d4069408ad38244a62b01e2546d23
https://doi.org/10.1016/j.ijpharm.2022.121987
https://doi.org/10.1016/j.ijpharm.2022.121987
Autor:
Olga A. Sukocheva, Mahadevaswamy G. Kuruburu, Jayashree Krishnamurthy, SubbaRao V. Madhunapantula, Rajesh K. Thimmulappa, Nanjunda Swamy Shivananju, Venugopal R. Bovilla, Vidya G Bettada, Janardhan P Balakrishna
Publikováno v:
Biomedicines
Volume 9
Issue 9
Biomedicines, Vol 9, Iss 1119, p 1119 (2021)
Volume 9
Issue 9
Biomedicines, Vol 9, Iss 1119, p 1119 (2021)
Nuclear factor erythroid-2 related factor-2 (Nrf2) is an oxidative stress-response transcriptional activator that promotes carcinogenesis through metabolic reprogramming, tumor promoting inflammation, and therapeutic resistance. However, the extensio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03fa69c372a2ba0d4b2959d1b388b13d
https://doi.org/10.3390/biomedicines9091119
https://doi.org/10.3390/biomedicines9091119
Autor:
Pallavi Chand, Siddharth S. Kesharwani, SubbaRao V. Madhunapantula, Vikas Jain, Surajit Dey, Vidya G Bettada, N. Vishal Gupta, Nihal Badduri, Hitesh Kumar
Publikováno v:
Colloids and Surfaces B: Biointerfaces. 199:111535
Cabazitaxel (CBZ) is a taxane derivative and an anti-microtubule agent effective against numerous cancers including drug-resistant cancers. In this study, CBZ loaded nanostructured lipid carriers (NLCs) were prepared by using Design-Expert (DoE) and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92b401e3c9a0a18075aaf92da8091cb5
https://doi.org/10.1016/j.colsurfb.2020.111535
https://doi.org/10.1016/j.colsurfb.2020.111535